Music helps prevent Alzheimer's development
Previous studies had already verified the diverse benefits that music has for a person's health and well-being. A few years ago, scientists at the Max Planck Institute for Neuroscience and Human Cognition in Leipzig, Germany, wondered why patients with Alzheimer's disease they were able to remember melodies or express strong emotions by listening to songs that marked their lives.
Researchers have discovered that music is stored in a different part of the brain that holds most of our memories. A documentary called "Alive Inside," showed this event in practice, portraying how an Alzheimer's patient began to respond to his past lucidly shortly after listening to a song. For researchers, music therapy that uses music and its elements - sound, rhythm, melody, and harmony - for the physical, mental and social rehabilitation of individuals or groups is essential for the treatment of Alzheimer's patients. In addition, music can still help in patient socialization.
Music can also help keep the memory of people who do not have Alzheimer's and can prevent the disease in the future. When we listen to music, our ear transforms the sounds into electrical stimuli that reach our brain, causing an increase in the production of endorphins.
"Our organism is endowed with a Sound Identity, called ISO, which commands our perception and sound production "When there is an imbalance in this system, the sick person feels less motivated and sadder and the music manages to bring back the balance that it needs," explains the founder and coordinator of FMU's music therapy course, Maristela Smith.
A Briton may have become one of the first people in the world to be cured of HIV. After receiving a vaccine that helps the immune system detect infected cells and take a medicine to activate latent infected cells - which are not usually captured by common treatments - the virus has completely disappeared from the patient's blood.
Last Tuesday (10), Anvisa (National Agency of Sanitary Surveillance) approved a new medication for adult patients newly diagnosed with acute myeloid leukemia. > The product is RYDAPT (Midostaurin), which should be used in conjunction with chemotherapy treatment as directed by a physician. The commercialization will be in the form of a soft capsule with a concentration of 25 mg.